Reporting guidelines for economic studies
1995; Wiley; Volume: 4; Issue: 2 Linguagem: Inglês
10.1002/hec.4730040202
ISSN1099-1050
AutoresJames Mason, Michael Drummond,
Tópico(s)Health Systems, Economic Evaluations, Quality of Life
ResumoHealth EconomicsVolume 4, Issue 2 p. 85-94 Guest EditorialFree Access Reporting guidelines for economic studies James Mason, James Mason Centre for Health Economics, University of York, UKSearch for more papers by this authorMichael Drummond, Michael Drummond Centre for Health Economics, University of York, UKSearch for more papers by this author James Mason, James Mason Centre for Health Economics, University of York, UKSearch for more papers by this authorMichael Drummond, Michael Drummond Centre for Health Economics, University of York, UKSearch for more papers by this author First published: March/April 1995 https://doi.org/10.1002/hec.4730040202Citations: 33AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Backhouse, M. E., Backhouse, R. J. and Edey, S. A. Economic evaluation bibliography. Health Economics 1992; 1: Suppl. 2 Elixhauser, A., Luce, B. R., Taylor, W. R. and Reblando, J. Health care CBA/CEA: an update on the growth and composition of the literature. Medical Care 1993; 31(7): JS1–JS11 3 Lee, J. T. and Sanchez, L. A. Interpretation of ‘cost effective’ and soundness of economic evaluations in the pharmacy literature. American Journal of Hospital Pharmacy 1991; 48: 2622–7. 4 Drummond, M. F., Stoddart, G. L. and Torrance, G. W. Methods for the economic evaluation of health care programmes. Oxford, Oxford University Press, 1987. 5 Udvarhelyi, I. S., Colditz, G. A., Rai, A. and Epstein, A. M. Cost-effectiveness and cost-benefit analysis in the medical literature: are methods being used correctly? Annals of Internal Medicine 1992; 116: 238–244. 6 Adams, M. E., McCall, N. T., Gray, D. T., et al. Economic analysis in randomized controlled trials. Medical Care 1992; 30: 231–243. 7 Gerard, K. Cost-utility in practice: a policy maker's guide to the state of the art. Health Policy 1992; 21: 249–279. 8 Gerard, K. Setting priorities in the new NHS: can purchasers use cost-utility information? Health Policy 1993; 25: 109–125. 9 Warner, K. E. and Hutton, R. C. Cost-benefit and cost-effectiveness analysis in health care. growth and composition of the literature. Medical Care 1980; 17: 1069–84 10 Drummond, M. F. Survey of cost-effectiveness and cost-benefit analyses in industrialised countries. World Health Statistics Quarterly, 1985; 38: 253–5. 11 Department of Health, Econonics and Operational Research Division. Register of Cost-Effectiveness studies. August 1994. 12 Mason, J. M. and Drummond, M. F. The DH register of cost-effectiveness studies: a review of content and quality. Centre for Health Economics, University of York. Discussion Paper 128. 1995. 13 Drummond, M. F. and Davies, L. Economic analysis alongside clinical trials: revisiting the methodological issues. International Journal of Technology Assessment in Health Care 1991; 7(4): 561–573. 14 Abbott, R. D. and McGee, D. Section 37: The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. In: W. B. Kannell, P. A. Woolf and R. J. Garrison (eds). The Framingham study. An epidemiological investigation of cardiovascular disease. US Dept. of Health, Education and Welfare publication NIH 87–2703. Bethesda, MD, Public Health Services, 1987. 15 Davey Smith, G., Song, F. and Sheldon, T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. British Medical Journal 1993; 306: 1367–73. 16 Kind, P., Rosser, R. and Williams, A. Valuation of quality of life: some psychometric evidence. In: Ed: M. W. Jones-Lee, The value of life and safety. North-Holland Publishing Company, 1982. 17 Briggs, A., Sculpher, M. and Buxton, M. J. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Economics 1994; 3: 95–104. Citing Literature Volume4, Issue2March/April 1995Pages 85-94 ReferencesRelatedInformation
Referência(s)